Live Breaking News & Updates on ராகேட் மூலதனம்

Stay updated with breaking news from ராகேட் மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Skyharbour Resources (TSXV:SYH) Investor Overview


This Skyharbour Resources profile is part of a paid investor education campaign.
Overview
Industry experts expect uranium prices to rise and the nuclear industry resurgence to start accelerating as uranium continues to play an integral role in the generation of clean, base-load, affordable and reliable energy globally. Despite a predicted demand for uranium topping 180 million pounds in 2020, a major supply-side response has played out in recent years and supply deficits have continued to grow. As uranium is needed for nuclear power, exploration and development companies focused on uranium-based assets could benefit significantly in the coming years as renewed investor interest comes back to the sector. ....

New York , United States , Nord Pas De Calais , United Kingdom , British Columbia , East Preston , West Sussex , Eagle Point , Key Lake , Moore Lake , Perth And Kinross , Hook Lake , Patterson Lake , Joseph Gallucci , Paul Matysek , Richard Kusmirski , Jim Pettit , Jamesg Pettit , Rick Kusmirski , Fraser Lakes , Goodman Institute Of Investment Management , Uranium Participation Corp , Rockgate Capital Corp , Kinross Gold Corp , Lithiumx Energy Corp , University Of British Columbia ,

Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer


Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer
Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced that it has appointed veteran corporate finance and capital markets professional, Gordon Neal to the Board of Directors. Additionally, Dean Ditto has joined the Company as Chief Financial Officer. “MYCO continues to …
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced that it has appointed veteran corporate finance and capital markets professional, Gordon Neal to the Board of Directors. Additionally, Dean Ditto has joined the Company as Chief Fi ....

United States , New Brunswick , British Columbia , Los Angeles , Nesbitt Burns , Josh Bartch , Charles Lee , Joshua Bartch , Gordon Neal , Anne Donohoe Nick Opich , Corp Communication , Bell Mobility , Bell Canada International , Mydecine Innovations Group Media Contacts , Vp Corporate Development , Mydecine Innovations Group , Pacific Metals Corp , Canadian Securities Exchange , Mydecine Innovations Group Inc , Indiana University , Dalhousie University , Silver Corp , Strategic Communications , Dalhousie University Senate , Kelley School Of Business , Health Canada ,